Share

May 24, 2022; 98 (21) Disputes & Debates: Editors' Choice

Reader Response: Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis

Ludger Tebartz van Elst, Kimon Runge, Dominique Endres, Marion Leboyer, Janet L. Cunningham
First published May 23, 2022, DOI: https://doi.org/10.1212/WNL.0000000000200723
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
12

Share

Article Information

vol. 98 no. 21 905-906
DOI: 
https://doi.org/10.1212/WNL.0000000000200723
PubMed: 
35606116
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 28, 2022
  • Accepted in final form March 28, 2022
  • First Published May 23, 2022.
Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Ludger Tebartz van Elst,
    2. Kimon Runge,
    3. Dominique Endres,
    4. Marion Leboyer and
    5. Janet L. Cunningham
  1. Ludger Tebartz van Elst,
  2. Kimon Runge,
  3. Dominique Endres,
  4. Marion Leboyer and
  5. Janet L. Cunningham
  1. (Freiburg im Breisgau, Germany)
  2. (Freiburg im Breisgau, Germany)
  3. (Freiburg im Breisgau, Germany)
  4. (Paris)
  5. (Uppsala, Sweden)
View Full Text

Article usage

Article usage: May 2022 to July 2022

AbstractFullPdfSource
May 2022319348Highwire
Jun 202211142Highwire
Jul 20225422Highwire

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me